Detalles de la búsqueda
1.
Accelerating the development of genetically engineered cellular therapies: a framework for extrapolating data across related products.
Cytotherapy
; 2024 Mar 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38583170
2.
Homologous Recombination Deficiency: Concepts, Definitions, and Assays.
Oncologist
; 27(3): 167-174, 2022 03 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35274707
3.
Need for aligning the definition and reporting of cytokine release syndrome (CRS) in immuno-oncology clinical trials.
Cytotherapy
; 24(7): 742-749, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35219582
4.
Exploring the Potential of External Control Arms created from Patient Level Data: A case study in non-small cell lung cancer.
J Biopharm Stat
; 32(1): 204-218, 2022 01 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34986069
5.
Accelerating the development of innovative cellular therapy products for the treatment of cancer.
Cytotherapy
; 22(5): 239-246, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32199724
6.
Tumor mutational burden standardization initiatives: Recommendations for consistent tumor mutational burden assessment in clinical samples to guide immunotherapy treatment decisions.
Genes Chromosomes Cancer
; 58(8): 578-588, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30664300
7.
The Value of Addressing Patient Preferences.
Value Health
; 20(2): 283-285, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28237210
8.
Shed syndecan-1 translocates to the nucleus of cells delivering growth factors and inhibiting histone acetylation: a novel mechanism of tumor-host cross-talk.
J Biol Chem
; 290(2): 941-9, 2015 Jan 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-25404732
9.
An Analysis of Dosing-Related Postmarketing Requirements for Novel Oncology Drugs Approved by the U.S. Food and Drug Administration, 2012-2022.
Clin Cancer Res
; 30(5): 937-941, 2024 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38085161
10.
An evaluation of novel oncology approvals with a PMR/C for assessing data in racial and ethnic populations underrepresented in premarket clinical trials.
Clin Cancer Res
; 2024 Jun 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38884580
11.
Advancing Evidence Generation for Circulating Tumor DNA: Lessons Learned from A Multi-Assay Study of Baseline Circulating Tumor DNA Levels across Cancer Types and Stages.
Diagnostics (Basel)
; 14(9)2024 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38732326
12.
Liquid biopsies coming of age: biology, emerging technologies, and clinical translation- An introduction to the JITC expert opinion special review series on liquid biopsies.
J Immunother Cancer
; 11(1)2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36657817
13.
Real-world Overall Survival Using Oncology Electronic Health Record Data: Friends of Cancer Research Pilot.
Clin Pharmacol Ther
; 111(2): 444-454, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34655228
14.
Changes in Circulating Tumor DNA Reflect Clinical Benefit Across Multiple Studies of Patients With Non-Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors.
JCO Precis Oncol
; 6: e2100372, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35952319
15.
Hospital certification for optimizing cardiovascular disease and stroke quality of care and outcomes.
Circulation
; 122(23): 2459-69, 2010 Dec 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-21098429
16.
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Laboratory Reference Ranges and Testing Intervals Work Group.
Clin Cancer Res
; 27(9): 2416-2423, 2021 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33563636
17.
Continuing to Broaden Eligibility Criteria to Make Clinical Trials More Representative and Inclusive: ASCO-Friends of Cancer Research Joint Research Statement.
Clin Cancer Res
; 27(9): 2394-2399, 2021 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33563632
18.
Omissions of Care in Nursing Homes: A Uniform Definition for Research and Quality Improvement.
J Am Med Dir Assoc
; 21(11): 1587-1591.e2, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32994119
19.
A National Assessment of Diagnostic Test Use for Patients with Advanced NSCLC and Factors Influencing Physician Decision-Making.
Am Health Drug Benefits
; 13(3): 110-119, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32699571
20.
Heparanase promotes myeloma stemness and in vivo tumorigenesis.
Matrix Biol
; 88: 53-68, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31812535